Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C1175175 (
SARS
)
19,188
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Type II transmembrane serine proteases (TTSPs) are a group of enzymes participating in diverse biological processes. Some members of the TTSP family are implicated in viral infection.
TMPRSS11A
is a TTSP expressed on the surface of airway epithelial cells, which has been shown to cleave and activate spike proteins of the
severe acute respiratory syndrome
(
SARS
) and the Middle East respiratory syndrome coronaviruses (CoVs). In this study, we examined the mechanism underlying the activation cleavage of
TMPRSS11A
that converts the one-chain zymogen to a two-chain enzyme. By expression in human embryonic kidney 293, esophageal EC9706, and lung epithelial A549 and 16HBE cells, Western blotting, and site-directed mutagenesis, we found that the activation cleavage of human
TMPRSS11A
was mediated by autocatalysis. Moreover, we found that
TMPRSS11A
activation cleavage occurred before the protein reached the cell surface, as indicated by studies with trypsin digestion to remove cell surface proteins, treatment with cell organelle-disturbing agents to block intracellular protein trafficking, and analysis of a soluble form of
TMPRSS11A
without the transmembrane domain. We also showed that
TMPRSS11A
was able to cleave the
SARS
-CoV-2 spike protein. These results reveal an intracellular autocleavage mechanism in
TMPRSS11A
zymogen activation, which differs from the extracellular zymogen activation reported in other TTSPs. These findings provide new insights into the diverse mechanisms in regulating TTSP activation.
...
PMID:Intracellular autoactivation of TMPRSS11A, an airway epithelial transmembrane serine protease. 3267 85